Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Chr Hansen
Chr Hansen
Activities:
Ingredients
Research & Development
Active Nutrition
Food
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Sustainability
Novozymes and Chr. Hansen join forces to create Novonesis
The two legacy companies collaborate to offer biosolutions to over 30 different industries
Chr Hansen and Lonza appoint new CEO for BacThera
Chr Hansen and Lonza joint venture company focuses on live-biotherapeutics has appointed Lukas Schüpbach as CEO
Ingredients
Chr. Hansen and Lonza joint venture: Ready for contract manufacturing
Companies have received the relevant approvals from anti-trust regulators for the 50/50 live biotherapeutic joint venture, BacThera
Manufacturing
Lonza and Chr. Hansen joint venture taps into microbiome boom
Companies engage in a three-year plan to provide a full supply chain offering for production of bacteria strains for therapeutic use
Design & Build
AF wins €5.5 million contract to modernise Chr Hansen plant
Will install a complete fermentation line for the production of probiotics at plant in Denmark
Subscribe now